Skip to content

New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

Victor Virlogeux and Bart Rijnders at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Three-drug regimen beats XDR-TB in first trial

Nix-TB patient in waiting area at Brooklyn Chest Hospital in Cape Town. Credit: John-Michael Maas for TB Alliance.

Stopping smoking cuts the risk of some cancers quickly in people with HIV

Leah Shepherd at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

How should HIV self-testing services be provided?

Pitchaya Indravudh at CROI 2017. Image by Roger Pebody

Unique case of PrEP failure without drug resistance reported from Amsterdam

Elske Hoornenborg and Godelieve de Bree at CROI 2017. Photo by Gus Cairns, aidsmap.com

New HIV infections fall in the US, but demographic and geographic disparities persist

New HIV infections fall in the US, but demographic and geographic disparities persist

Isoniazid preventive treatment reduces the risk of death by 37% in people living with HIV

Anani Badje at CROI 2017. Photo credit: Robb Cohen Photography & Video

Treatment or watchful waiting for cervical abnormalities in women with HIV?

Sharon Greene at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Tenofovir/emtricitabine/efavirenz less likely to cause adverse birth outcomes than other regimens, Botswana study finds

Rebecca Zash at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com